26 results
PRE 14A
CNTA
Centessa Pharmaceuticals plc
26 Apr 24
Preliminary proxy
4:36pm
developing and commercializing innovative products, services and technologies. Dr. Zbar began his career in McKinsey & Company’s Pharmaceuticals and Medical
8-K
EX-99.2
CNTA
Centessa Pharmaceuticals plc
14 Aug 23
Centessa Pharmaceuticals Reports Financial Results and Business Highlights for the Second Quarter of 2023
7:06am
.
DIFFERENTIATION We are a transformational pharmaceutical company fueling an innovative pipeline 4 Lead Assets Disease Estimated Market Size* SerpinPC … infrastructure Data-driven ‘go / no-go’ decisions Innovative and uncorrelated assets Asset-Centric. Patient-Centric. Centessa has multiple early-stage
8-K
EX-99.1
CNTA
Centessa Pharmaceuticals plc
9 Jun 23
Regulation FD Disclosure
7:10am
pharmaceutical company fueling an innovative pipeline 4 Lead Assets Disease Estimated Market Size* SerpinPC Hemophilia B $2B+1 PD-L1xCD47 LockBody® (LB101 … ’ decisions Innovative and uncorrelated assets Asset-Centric. Patient-Centric. Centessa has multiple early-stage programs, including MGX292 and discovery
8-K
EX-99.2
44d2via
30 Mar 23
Centessa Pharmaceuticals Reports Recent Business Progress and Financial Results for the Fourth Quarter and Full-Year 2022
7:19am
8-K
EX-99.1
75w4j tkfx2
12 Sep 22
Regulation FD Disclosure
7:16am
8-K
EX-99.2
lhuk3 a4zmb
2 Jun 22
Cost Associated with Exit or Disposal Activities
6:33am
8-K
EX-99.1
4balqwo3lm
2 Jun 22
Cost Associated with Exit or Disposal Activities
6:33am
DEF 14A
8xbfd84 k2ogai9
23 May 22
Definitive proxy
8:00am
8-K
EX-99.1
l40mpi5 sbv
16 May 22
Centessa Pharmaceuticals Reports First Quarter 2022 Financial Results and Provides Business Updates
7:14am
8-K
EX-99.1
x501day
30 Mar 22
Centessa Pharmaceuticals Reports Fourth Quarter and 2021 Financial Results and Provides Business Update
4:06pm
10-K
6se9zz
30 Mar 22
Annual report
12:00am
8-K
EX-99.1
pw6hw4tuu6f5czc
15 Nov 21
Centessa Pharmaceuticals Announces Third Quarter 2021 Financial Results and Business Updates
7:11am
8-K
EX-99.1
bx2rh6
4 Oct 21
Centessa Pharmaceuticals Announces $300 Million Financing Agreement with Oberland Capital
8:07am
10-Q
wt3x8iuu8t3nvc
16 Aug 21
Quarterly report
7:07am